Pfizer vaccine in final stages to get approval in India: CEO Albert Bourla
As the COVID vaccination drive is underway in the country, Pfizer CEO Albert Bourla on Tuesday said that its vaccine…
As the COVID vaccination drive is underway in the country, Pfizer CEO Albert Bourla on Tuesday said that its vaccine…
Covaxin has inched a step closer to WHO emergency use listing. The pre-submission meeting with WHO is now planned for…
According to Ministry of Health, India registered 60,471 new COVID-19 cases, which is the fewest in about 77 days on…
India is now facing a major vaccine shortage in the country. This is one of the reasons that India is…
In India, the price of a single dose Pfizer’s COVID 19 vaccine is predicted to be priced under $10 (about…
The Pfizer Covid-19 vaccine authorised for use in children below 12 in the US and Canada; EMA evaluating Moderna vaccine…
We present you the impact of COVID-19 on the global economy.
Serum Institute of India (SII), the Covishield maker has requested for indemnity from liability. As per reports, the company said…
A major demand of granting indemnity may get accepted as it has been done in many countries around the world,…
On Tuesday, India’s apex drug regulator expressed the requirement to conduct post-launch bridging trials and test the quality and stability…
We present you the top 5 COVID-19 vaccine makers across the world.
As the second wave of coronavirus cases began to spread across the country, the Modi government has been on a…